Sulfapyridine
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: piridazol, pirodazole, plurazol, pyridazol, streptosilpyridine, sulfidin, sulfidine, sulphapyridine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Sulfapyridine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1939. DrugCentral lists 2 molecular targets, including folP and sulI. Recorded indications include Dermatitis herpetiformis.
- Approval status: ofm (first approved 1939 by the FDA).
- Molecular targets: folP and sulI (2 listed in DrugCentral).
- Indications: Dermatitis herpetiformis.
- ATC code: J01EB04 (Short-acting sulfonamides).
- Molecular formula: C11H11N3O2S; molecular weight 249.29 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Dermatitis herpetiformis
Off-label uses (3)
- Pemphigoid
- Pyoderma gangrenosum
- Subcorneal pustular dermatosis
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Dihydropteroate synthase | folP | inhibitor | — |
| Dihydropteroate synthase type-1 | sulI | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1939-03-09 | FDA | — | LILLY |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01EB04 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Short-acting sulfonamides |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Sulfapyridine is on its molecule page.
| Molecular formula | C11H11N3O2S |
|---|---|
| Molecular weight | 249.29 g/mol |
| CAS number | 144-83-2 |
| InChIKey | GECHUMIMRBOMGK-UHFFFAOYSA-N |
| PubChem CID | 5336 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Sulfapyridine used for?
DrugCentral lists the following indications for Sulfapyridine: Dermatitis herpetiformis.
How does Sulfapyridine work?
Its molecular targets in DrugCentral include folP (inhibitor) and sulI.
When was Sulfapyridine first approved?
Sulfapyridine was first approved by the FDA in 1939.
What is the chemical formula of Sulfapyridine?
Sulfapyridine has the molecular formula C11H11N3O2S and a molecular weight of 249.29 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2524 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL700 — compound record and bioactivity
- PubChem CID 5336 — chemical identifiers
- DrugBank DB00891 — drug record
- FDA UNII Y5V2N1KE8U — substance identity
- DailyMed: FDA labels for Sulfapyridine — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.